Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cristal: Tunable nanoparticles

Cristal using tunable polymeric nanoparticles to improve therapeutic profiles

Cristal Therapeutics aims to improve the therapeutic profile of drugs by entrapping them within biodegradable polymeric nanoparticles. While the company's CriPec platform has several characteristics in common with other polymer-based nanoparticle carriers, it may be better able to increase efficacy and safety.

The platform uses thermosensitive polymers that self-assemble into micelles when the temperature is raised above a critical level. During the process, sections of the polymers that make up the micelle core polymerize and form crosslinks with one another, thus stabilizing

Read the full 810 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE